AstraZeneca has announced a sweeping $50 billion investment across the United States through 2030, marking the company’s largest commitment to U.S. pharmaceutical operations to date. The move signals ...

Democrats assert in the court case that the vote of a Senate committee rejecting the appointees means they cannot serve. A ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...

The Trump trade deals should be major boosts to the American economy, and more deals are on the way. It was a special opportunity and I was honored to be present for the finalization of such an ...

Results from the Phase III PREVAIL trial (NCT05556096) of gefurulimab demonstrated a statistically significant and clinically ...

AstraZeneca's shares are up 3.5% over the year to date but remain down 11% over the past 52 weeks.

Another FTSE 100-listed ( ^FTSE) giant reporting in the week ahead is pharmaceuticals company AstraZeneca ( AZN.L ), which ...

In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...

Governor Glenn Youngkin spoke with 8News about AstraZeneca’s recent announcement to build their world’s-largest manufacturing ...

The deal, which Youngkin signed on Monday, has not been reviewed by the Democrat-controlled General Assembly. The governor ...

The pharma sees the drug, gefurulimab, as a more convenient, self-administered alternative to the infused medicines it sells ...

Sen. Tim Kaine has been involved with bringing pharmaceutical reseach and development to central Virginia since his days on ...